CPT® 0465U, Under Proprietary Laboratory Analyses
The Current Procedural Terminology (CPT®) code 0465U as maintained by American Medical Association, is a medical procedural code under the range - Proprietary Laboratory Analyses.
Subscribe to Codify by AAPC and get the code details in a flash.
Tabs
Summary
This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0465U only for UriFind® cancer assay from DiaCarta Inc. and AnchorDx. The test analyzes a sample to detect specific DNA changes that involve methylation, a chemical modification, of two DNA markers (ONECUT2 and VIM). The results are then reported as either a positive or negative result. A positive result indicates the presence of these methylation markers and suggests a high risk of bladder cancer in the patient.
For clinical responsibility, terminology, tips and additional info
start codify free trial.
View any code changes for 2024 as well as historical information on code creation and revision.
Tabs
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.
Read a CPT® Assistant article by subscribing to Code Connect Today!
Search across Medicare Manuals, Transmittals, and more. For FREE Trial, register now!